Ardelyx (ARDX) (ADRX) announced the appointment of Sue Hohenleitner as Chief Financial Officer, CFO, effective November 4, 2025. Hohenleitner most recently served as the Vice President and Chief Financial Officer of Johnson & Johnson (JNJ) Innovative Medicine North America
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX: